Skip to main content
. 2020 Jan 29;12(2):314. doi: 10.3390/cancers12020314

Figure 3.

Figure 3

ROC curves of valine (A) and TNF-α (B) diagnostic power to distinguish ER(+) patients who achieve pathological response (GR) from those who achieve only a partial response (PR) to NATC treatment. The ROC curve of the combined linear model VAL+TNF-α (C) shows improved diagnostic power.